OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
April 10, 2010
CMS will be changing reimbursement practices regardless of how healthcare reform plays out
August 22, 2009
The most basic impulse behind CER is the desire to control healthcare costs. The implications for the biopharma industry could be significant